Emily V Nosova1, Karen C Chong1, Hugh F Alley1, William S Harris2, W John Boscardin3, Michael S Conte4, Christopher D Owens5, S Marlene Grenon6. 1. Department of Surgery, University of California, San Francisco, San Francisco, Calif; VIPERx Laboratory, San Francisco, Calif. 2. Department of Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SDak; Health Diagnostic Laboratory, Inc, Richmond, Va. 3. Departments of Medicine and of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif. 4. Department of Surgery, University of California, San Francisco, San Francisco, Calif; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, Calif. 5. Department of Surgery, University of California, San Francisco, San Francisco, Calif; VIPERx Laboratory, San Francisco, Calif; Department of Surgery, Veterans Affairs Medical Center, San Francisco, Calif. 6. Department of Surgery, University of California, San Francisco, San Francisco, Calif; VIPERx Laboratory, San Francisco, Calif; Department of Surgery, Veterans Affairs Medical Center, San Francisco, Calif. Electronic address: marlene.grenon@ucsfmedctr.org.
Abstract
OBJECTIVE: Despite available medical therapies, patients with peripheral arterial disease (PAD) remain at high risk for cardiovascular events. The n-3 polyunsaturated fatty acids (PUFA), derived from marine sources, have been shown to improve cardiovascular mortality. The Omega-3 Index (O3I), a proportion of the n-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the red blood cell membrane, correlates with cardiovascular risk. Previous investigations have found that n-3 PUFA supplementation, fish consumption, older age, and smoking history affect the O3I in different patient populations, although similar correlations have never been explored in PAD. We hypothesized that in our PAD cohort, blood content of omega-3 fatty acids would directly and positively correlate with a history of fish oil supplementation and older age and inversely correlate with a smoking history and obesity. METHODS: This cross-sectional study included 111 patients who had an ankle-brachial index of <0.9 associated with claudication symptoms. We used linear regression to determine the association between clinical factors and the O3I. RESULTS: The mean age of the cohort was 69 ± 8 years; 37% had diabetes mellitus (hemoglobin A1c, 7% ± 1%), and 94% reported current smoking or a history of smoking. The mean O3I was 5% ± 2%. In multivariate linear regression analysis, the O3I was associated with older age, increasing body mass index, and a history of smoking and fish oil intake. CONCLUSIONS: This is the first report of the relation between blood content of omega-3 fatty acids and clinical factors in a PAD population. In patients with PAD, older age, elevated body mass index, and prior fish oil supplementation predicted a higher O3I. A history of smoking correlated with a lower O3I. These results demonstrate that the O3I is a reliable measure of dietary n-3 PUFA intake and that clinical factors related to the O3I in PAD are similar to those observed in other populations. Published by Elsevier Inc.
OBJECTIVE: Despite available medical therapies, patients with peripheral arterial disease (PAD) remain at high risk for cardiovascular events. The n-3 polyunsaturated fatty acids (PUFA), derived from marine sources, have been shown to improve cardiovascular mortality. The Omega-3 Index (O3I), a proportion of the n-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the red blood cell membrane, correlates with cardiovascular risk. Previous investigations have found that n-3 PUFA supplementation, fish consumption, older age, and smoking history affect the O3I in different patient populations, although similar correlations have never been explored in PAD. We hypothesized that in our PAD cohort, blood content of omega-3 fatty acids would directly and positively correlate with a history of fish oil supplementation and older age and inversely correlate with a smoking history and obesity. METHODS: This cross-sectional study included 111 patients who had an ankle-brachial index of <0.9 associated with claudication symptoms. We used linear regression to determine the association between clinical factors and the O3I. RESULTS: The mean age of the cohort was 69 ± 8 years; 37% had diabetes mellitus (hemoglobin A1c, 7% ± 1%), and 94% reported current smoking or a history of smoking. The mean O3I was 5% ± 2%. In multivariate linear regression analysis, the O3I was associated with older age, increasing body mass index, and a history of smoking and fish oil intake. CONCLUSIONS: This is the first report of the relation between blood content of omega-3 fatty acids and clinical factors in a PAD population. In patients with PAD, older age, elevated body mass index, and prior fish oil supplementation predicted a higher O3I. A history of smoking correlated with a lower O3I. These results demonstrate that the O3I is a reliable measure of dietary n-3 PUFA intake and that clinical factors related to the O3I in PAD are similar to those observed in other populations. Published by Elsevier Inc.
Authors: A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: John S Lane; Cheryl P Magno; Karen T Lane; Tyler Chan; David B Hoyt; Sheldon Greenfield Journal: J Vasc Surg Date: 2008-06-30 Impact factor: 4.268
Authors: D S Siscovick; T E Raghunathan; I King; S Weinmann; K G Wicklund; J Albright; V Bovbjerg; P Arbogast; H Smith; L H Kushi Journal: JAMA Date: 1995-11-01 Impact factor: 56.272
Authors: Michael R Flock; Ann C Skulas-Ray; William S Harris; Terry D Etherton; Jennifer A Fleming; Penny M Kris-Etherton Journal: J Am Heart Assoc Date: 2013-11-19 Impact factor: 5.501
Authors: H J Murff; H A Tindle; M J Shrubsole; Q Cai; W Smalley; G L Milne; L L Swift; R M Ness; W Zheng Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2016-08-16 Impact factor: 4.006
Authors: Laura M Drudi; Melinda S Schaller; Jade Hiramoto; Warren Gasper; William S Harris; Nancy K Hills; S Marlene Grenon Journal: J Surg Res Date: 2016-11-11 Impact factor: 2.192
Authors: Harvey J Murff; Robert A Greevy; Reesha S Sanghani; Katherine E Hartmann; Tina V Hartert; Cornelia R Graves; Scott S Lee; Hilary A Tindle Journal: Trials Date: 2021-12-14 Impact factor: 2.279